Introdução: A anemia e a carência de ferro são problemas de saúde globais e são mais frequentes em grávidas, mulheres em idade reprodutiva e crianças. O objetivo deste trabalho consistiu na avaliação da prevalência de anemia ferropénica e dos fatores de risco associados à ferropénia, na primeira metade da gravidez, numa amostra da população portuguesa. ABSTRACT Introduction: Anemia and iron deficiency during pregnancy are a worldwide concern and are more frequent among women of reproductive age, pregnant women, and young children. The aim of this study was to assess the prevalence of iron deficiency anemia and the risk factors for iron depletion during the first half of pregnancy, in a Portuguese population.
INTRODUCTION
Anemia and iron deficiency affect billions of people worldwide and are more common among women of reproductive age, pregnant women, and young children. Globally, anemia is found in more than 20% of pregnancies. The highest rates are found in developing countries, with an estimated prevalence of 55.8% and 41.6% in Africa and Asia, respectively. [1] [2] [3] In developed countries, according to the World Health Organization (WHO), this percentage falls to 18%. 1, 4 In Portugal, following the Empire Study, the incidence of anemia is slightly higher (19.9%) and is more common in pregnancy. 5 During pregnancy, anemia is defined as a hemoglobin (Hb) concentration < 11.0 g/dL in the first and third trimesters and Hb < 10.5 g/dL in the second trimester. 6 Multiple factors may lead to anemia during this period, namely nutritional deficiencies, hemolysis and abnormal hemoglobin synthesis, blood loss, defective iron absorption and metabolism, and chronic conditions. Iron-deficiency (ID) is the most common cause of anemia in pregnancy. The spectrum of ID ranges from iron depletion, to deficient erythropoiesis and to iron deficient anemia. 6, 8 The prevalence of ID can be 2 -2.5 times that of iron deficiency anemia (IDA). The risk factors related to IDA include teenage pregnancy, high parity, multiple pregnancies and reduced inter-pregnancy intervals. 2, 7 A previous study analysed the iron status of pre-pregnant women and concluded that 36.5% of these had low iron stores, therefore presenting a higher risk of becoming iron deficient during their pregnancy. 8 Furthermore, iron requirements increase for pregnant women and are difficult to achieve by diet alone. 1, 3, 6 Iron deficiency anemia has been linked to negative maternal-fetal outcomes. For mothers, these include reduced working and intellectual capacity, increased susceptibility to infection, higher risk of post-partum anemia and depression. 2, 9 The perinatal outcomes include premature delivery, small for gestational age infants, a highest risk of anemia and poor physical and mental growth during infancy.
2,7,9-11 Therefore, the diagnosis of IDA and its treatment has a positive impact. 2, 9, 11, 12 Moreover, current guidelines recommend a daily iron supplementation of at least 60 mg of elemental iron after the 16 th -20 th week of gestation or sooner if there are any risk factors. 1, 13, 14 The iron status can be determined by a serum ferritin (SF) assay that has the highest sensitivity and specificity to diagnose iron deficiency. 7, 15 Serum ferritin identifies iron deficiency earlier than other biomarkers such as Hb and transferring saturation (TS) but can be increased in the presence of inflammation or infection. If SF is < 30 μg/L, there is a 90% certainty that the iron stores are depleted, even if there is no anemia. A value < 15 μg/L, provides clear evidence for IDA. 7, 9, 11 The treatment of IDA depends on the severity of the anemia. In mild cases, the primary treatment includes oral iron therapy. In more severe cases, intravenous iron may be used as parenteral iron results in a faster increase in Hb levels. If a critical value of Hg is achieved, blood transfusion has to be considered. 12, 14, 15 With this study we seek to assess the occurrence of anemia and iron deficiency in a Portuguese population, as well as the risk factors for iron deficiency during the first half of pregnancy.
MATERIAL AND METHODS
A prospective study was conducted between February 2013 and September 2014 at the Department of Obstetrics and Gynecology of Hospital de Santa Maria, a tertiary university/public hospital in Lisbon, Portugal. In our Hospital, there are about 2,300 deliveries per year. The study was approved by the Hospital's Ethics Committee (Protocol number 936/12). An informed consent was obtained before enrolment.
All women attending their first hospital visit for antenatal care at 20 weeks or less were invited to participate in the present study. Exclusion criteria included iron supplementation, clinical history of hematological disease, chronic inflammation, infection or malignancies, and blood transfusions in the previous 6 months.
At their first medical appointment, clinical and obstetric histories were thoroughly collected and venous blood samples were taken for a full blood count and serum ferritin determination. Serum ferritin was measured by quimiluminescent assay.
Baseline data was also collected, comprising maternal age, ethnic group, parity, body mass index (BMI), smoker status, level of education, single/multiple gestation and gestational age at the time when laboratory tests were performed. Anemia was defined as Hb < 11.0 g/dL in the first trimester (before the 14 th week of pregnancy) and 10.5 g/dL in the second (from the 14 th to the 27 th week of pregnancy). Iron depletion was defined as a SF < 30 mg/L and severe iron depletion as a SF < 15 mg/L. Two groups of women were compared based on the concentration of SF: without iron deficiency (SF ≥ 30 mg/L) and with iron deficiency (SF < 30 mg/L). The following potential risk factors were examined: age, race, parity, body mass index, multiple gestations, level of education and smoker status. For a secondary outcome of this study, a sub-analysis was conducted to analyse women with severe iron depletion (SF < 15 m/L).
Statistical analysis was performed with SPSS software version 2.0 (SPSS Inc., Chicago, IL, USA). A sample size was calculated to evaluate the prevalence of maternal anemia, and, for a maximum error of 0.05, ninety women had to be enrolled in the study.
The Kolmogorov-Smirnoff test was used to assess the normality of the data distribution.
Multivariate logistic regression analysis was performed to analyse potential risk factors for decreased iron stores. p-value < 0.05 was considered to be statistically significant.
RESULTS
Two hundred and one women were included, whose demographic characteristics are shown in Table 1 . The median of maternal age was 31 years and the mean gestational age at enrolment was 11.2 ± 3.1 weeks. The mean hemoglobin concentration at the baseline was 12.8 ± 0.9 g/dL and the median of serum ferritin was 39.0 mg/L (3.8 -245.0 mg/L).
In the study group, the prevalence of maternal anemia was 2.49% (5/201). However, 38.3% (77 women) already showed decreased levels of iron (SF < 30 mg/L). Out of these, 10.9% (22 women) had severe iron depletion, defined as SF < 15 mg/L.
Overall, there were no statistically significant differences between women with normal SF and depleted iron stores regarding maternal age, race, parity, BMI, smoker status, university degree, multiple gestation and gestational age at enrolment in the study. The sub-analysis between women with normal SF and with severe iron deficiency (SF < 15 mg/L) didn't show any differences as well, except for the haemoglobin level, which was lower in the last group (Table  2) .
However, the multivariate logistic regression analysis showed that the odds ratio for iron deficiency increased in younger and older women. The odds ratio (OR) was 12.99 (95% CI 2.41 -70.0) for women under twenty years of age and 2.09 (95% CI 1.05 -4.14) for women over thirty years of age. In our study, race, parity, BMI, multiple gestation, level of education and smoker status were not linked to an increased risk of iron deficiency (Table 3) .
DISCUSSION AND CONCLUSION
Anemia and iron status are important determinants of maternal and infant health and are linked to negative pregnancy outcomes. 3 Data on maternal anemia and its predictors is limited in Portugal as few studies were published.
Our study group showcased a 2.5% prevalence of anemia, lower than the one reported in other studies, 1, [16] [17] [18] with the exception of a Swiss study that also reported a low prevalence of IDA during pregnancy (3%). 19 The lower prevalence of IDA may be due to the demographic features of our study group, which only included women until the 20 th week of pregnancy. As anemia during pregnancy increases more than a 4-fold from the first to the third trimester, the prevalence of anemia would be probably higher in late pregnancy, in women without iron supplementation.
As expected, the prevalence of iron depletion was higher than IDA. In the first half of the pregnancy, more than one-third of our study group had low serum ferritin concentrations (SF < 30 mg/L) and 11% had severe iron depletion. In agreement with former studies, our findings conclude that maternal age is a risk factor for iron deficiency in the first half of pregnancy. Women older than thirty-yearsold had a 2-fold higher risk of iron deficiency and women under twenty-years-old had almost a 13-fold higher risk for iron deficiency. No other risk factors were found among our study parameters, which also included race, body mass index, level of education and smoker status. We also did not find a correlation between parity and lower serum ferritin concentrations. Unexpectedly, the prevalence of IDA and iron deficiency didn't differ between simple and multiple pregnancies. However, due to the small number of multiple pregnancies included (n = 15), these results should be interpreted with caution. These results are relevant given the lack of data regarding anemia during pregnancy in Portugal, and to alert clinicians to the high prevalence of iron depletion in pregnant women, becoming at risk of developing anemia. The best moment to evaluate maternal iron status is in the early stages of pregnancy, before the plasma is fully expanded. Also, in the first trimester, it may be beneficial to evaluate the serum ferritin, to identify women with iron depletion and at risk of anemia. 6 A low SF may warrant an early intervention and iron status improvement with iron supplementation. The positive effects of adequate iron supplementation during pregnancy are well known and include improved birth weight and reduction in preterm labour and perinatal morbidity. These effects extend into the postnatal period with improved maternal Hb concentrations four to eight weeks postpartum. 12, 20, 21 Nonetheless, clinicians should also be aware of the increased risk of adverse maternal and neonatal outcomes linked to excess of iron and high hemoglobin concentrations. Studies have found an increased risk of low birth weight, preterm birth and small for gestational age infants, while others have showed that iron supplementation in nonanemic women did not affect birth weight. 20, 21 Therefore, iron supplementation in pre-pregnancy and early in pregnancy may be considered, only for women with low serum ferritin concentration and anemia. 6, 12, 20 This study presents some limitations. It included only fifteen multiple pregnancies which is probably insufficient to provide reliable conclusions regarding this group. As in most studies, we used a cut-off of 30 mg/L to define iron deficiency. However, lower cut-offs have been used (ex. SF < 20 mg/L), sustaining why the prevalence of iron deficiency in our study may be higher. To minimize this constraint a sub-analysis was performed to evaluate pregnant women with severe iron depletion (SF < 15 mg/L). Although SF is the best biochemical parameter for iron deficiency, a known limitation of this marker is that it increases with inflammation, infection or malignancy. Some authors believe that transferrin saturation (TS) should also be determined to identify errors, as its value doesn't increase with inflammation. In addition, an assessment of C-reactive protein (CRP) levels would help to identify those cases. We didn't determine the TS nor the CRP, as it would add additional costs to the study. However, the clinical history of each potential participant was thoroughly collected, prior to their enrolment, to exclude those with evidence of infection or inflammation.
Although our sample includes healthy women with uncomplicated pregnancies surveyed at our prenatal consult, we should be cautioned when generalizing these findings to the general population. For that, more studies should be conducted, preferably multicentre, and in Health Centres in order to gather a larger group of eligible subjects.
In conclusion, our findings indicate that, although maternal anemia in the first half of pregnancy seems to be lower in Portugal than in other countries, more than onethird of the study subjects had low ferritin concentrations and increased risk of anemia. Maternal age was the only risk factor identified, especially for teenage women, implying that iron depletion may affect all pregnant women, regardless of race, parity, body mass index, level of education and smoker status. Maternal anemia and iron deficiency are preventable risks factors for adverse maternal and birth outcomes, and iron supplementation may be considered not only after the 16 th -20 th week of pregnancy but also earlier if iron reserves are low. Despite our results, more studies should be conducted,
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